[Congressional Record Volume 168, Number 133 (Saturday, August 6, 2022)]
[Senate]
[Page S4337]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 5412. Mr. BARRASSO (for himself, Ms. Collins, and Mr. Wicker) 
submitted an amendment intended to be proposed to amendment SA 5194 
proposed by Mr. Schumer to the bill H.R. 5376, to provide for 
reconciliation pursuant to title II of S. Con. Res. 14; which was 
ordered to lie on the table; as follows:

        At the end of title I, add the following:

Subtitle E--Ensuring Access to Drugs and Biological Products That Treat 
                      Rare Diseases and Conditions

     SEC. 14001. ENSURING ACCESS TO DRUGS AND BIOLOGICAL PRODUCTS 
                   THAT TREAT RARE DISEASES AND CONDITIONS.

       Sec. 1192(e)(3)(A) of the Social Security Act, as added by 
     section 11001, is amended to read as follows:
       ``(A) Certain orphan drugs.--A drug that is designated 
     under section 526 of the Federal Food, Drug, and Cosmetic Act 
     for a rare disease or condition and is approved only for an 
     indication or indications for a rare disease or condition.''.

     SEC. 14002. REDUCTION OF ADDITIONAL IRS FUNDING FOR 
                   OPERATIONS SUPPORT.

       Section 10301(a)(1)(A)(i)(III) of this Act is amended by 
     striking ``$25,326,400,000'' and inserting 
     ``$10,326,400,000''.
                                 ______